Chemistry: analytical and immunological testing – Lipids – triglycerides – cholesterol – or lipoproteins
Reexamination Certificate
2008-12-18
2011-12-27
Wallenhorst, Maureen (Department: 1777)
Chemistry: analytical and immunological testing
Lipids, triglycerides, cholesterol, or lipoproteins
C436S063000, C514S007400, C424S009200
Reexamination Certificate
active
08084261
ABSTRACT:
Methods for using TRL V6 as a biomarker for the modulation of triglyceride and/or lipoprotein metabolism in a mammal induced by a weight loss pharmaceutical agent. The biomarker may be used for determining if an individual patient will likely respond favorably to a given weight loss pharmaceutical agent.
REFERENCES:
patent: 5343389 (1994-08-01), Otvos
patent: 6617167 (2003-09-01), Otvos et al.
patent: 2005/0169839 (2005-08-01), Fong et al.
patent: 2005/0222504 (2005-10-01), Otvos et al.
patent: 0051054 (2000-08-01), None
patent: 2007039184 (2007-12-01), None
Westman et al. International Journal of Cardiology, vol. 110, 2006, pp. 212-216.
Karpe, et al, “Differences in Postprandial Concentrations of Very-Low-Density Lipoprotein and Chylomicron Remnants Between Normotriglyceridemic and Hypertriglyceridemic Mem With and Without Coronary Heart Disease”; Metabolism, vol. 48, No. 3 Mar. 1999; pp. 301-307.
Otvos, et al., “NMR Lipoprotein Subclass Analysis: NMR LipoProfile Research Service Description”—Research and Development Division, James Otvos, Ph.D.,Chief Scientific Officer.
Otvos, “Technical Bulletin—Mar. 1, 2004, NMR LipoProfile—II Subclass Particle Analysis”, James D. Otvos, LipoScience, Inc.
Otvos, “NMR LipoProfile Data Analysis Guide”, 2003.
Otvos, “Measurement of Lipoprotein Subclass Profiles by Nuclear Magnetic Resonance Spectroscopy” supplied by the British Library—“The world's Knowledge”, pp. 609-623.
Suter, et al., “Effect of orlistat on postprandial lipemia, NMR lipoprotein subclass profiles and particle size”, Atherosclerosis, 180, 2005, pp. 127-135.
Eli Lilly and Company
Tucker R. Craig
Wallenhorst Maureen
LandOfFree
Method for predicting responsiveness to a pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for predicting responsiveness to a pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for predicting responsiveness to a pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4306762